Fetal Growth Restriction

Survivors of extranodal non-Hodgkin lymphoma had higher risks of SGA infants and low birth weight in their first live singleton birth conceived after diagnosis.

Effect: decline; RR=2.3; CI: 95% CI: 1.5, 3.6

Survivors of extranodal non-Hodgkin lymphoma had higher risks of SGA infants and low birth weight in their first live singleton birth conceived after diagnosis.

Effect: decline; RR=2.3; CI: 95% CI: 1.5, 3.6

Survivors of extranodal non-Hodgkin lymphoma had higher risks of SGA infants and low birth weight in their first live singleton birth conceived after diagnosis.

Effect: decline; RR=2.3; CI: 95% CI: 1.5, 3.6

Survivors of extranodal non-Hodgkin lymphoma had higher risks of SGA infants and low birth weight in their first live singleton birth conceived after diagnosis.

Effect: decline; RR=2.3; CI: 95% CI: 1.5, 3.6

Survivors of extranodal non-Hodgkin lymphoma had higher risks of SGA infants and low birth weight in their first live singleton birth conceived after diagnosis.

Effect: decline; RR=2.3; CI: 95% CI: 1.5, 3.6

Survivors of extranodal non-Hodgkin lymphoma had higher risks of SGA infants and low birth weight in their first live singleton birth conceived after diagnosis.

Effect: decline; RR=2.3; CI: 95% CI: 1.5, 3.6

Survivors of extranodal non-Hodgkin lymphoma had higher risks of SGA infants and low birth weight in their first live singleton birth conceived after diagnosis.

Effect: decline; RR=2.3; CI: 95% CI: 1.5, 3.6

Survivors of extranodal non-Hodgkin lymphoma had higher risks of SGA infants and low birth weight in their first live singleton birth conceived after diagnosis.

Effect: decline; RR=2.3; CI: 95% CI: 1.5, 3.6

Survivors of extranodal non-Hodgkin lymphoma had higher risks of SGA infants and low birth weight in their first live singleton birth conceived after diagnosis.

Effect: decline; RR=2.3; CI: 95% CI: 1.5, 3.6

Survivors of extranodal non-Hodgkin lymphoma had higher risks of SGA infants and low birth weight in their first live singleton birth conceived after diagnosis.

Effect: decline; RR=2.3; CI: 95% CI: 1.5, 3.6

Survivors of extranodal non-Hodgkin lymphoma had higher risks of SGA infants and low birth weight in their first live singleton birth conceived after diagnosis.

Effect: decline; RR=2.3; CI: 95% CI: 1.5, 3.6

Survivors of extranodal non-Hodgkin lymphoma had higher risks of SGA infants and low birth weight in their first live singleton birth conceived after diagnosis.

Effect: decline; RR=2.3; CI: 95% CI: 1.5, 3.6

Survivors of extranodal non-Hodgkin lymphoma had higher risks of SGA infants and low birth weight in their first live singleton birth conceived after diagnosis.

Effect: decline; RR=2.3; CI: 95% CI: 1.5, 3.6

Survivors of extranodal non-Hodgkin lymphoma had higher risks of SGA infants and low birth weight in their first live singleton birth conceived after diagnosis.

Effect: decline; RR=2.3; CI: 95% CI: 1.5, 3.6

Survivors of extranodal non-Hodgkin lymphoma had higher risks of SGA infants and low birth weight in their first live singleton birth conceived after diagnosis.

Effect: decline; RR=2.3; CI: 95% CI: 1.5, 3.6

Survivors of extranodal non-Hodgkin lymphoma had higher risks of SGA infants and low birth weight in their first live singleton birth conceived after diagnosis.

Effect: decline; RR=2.3; CI: 95% CI: 1.5, 3.6

Survivors of extranodal non-Hodgkin lymphoma had higher risks of SGA infants and low birth weight in their first live singleton birth conceived after diagnosis.

Effect: decline; RR=2.3; CI: 95% CI: 1.5, 3.6

Survivors of extranodal non-Hodgkin lymphoma had higher risks of SGA infants and low birth weight in their first live singleton birth conceived after diagnosis.

Effect: decline; RR=2.3; CI: 95% CI: 1.5, 3.6

Survivors of extranodal non-Hodgkin lymphoma had higher risks of SGA infants and low birth weight in their first live singleton birth conceived after diagnosis.

Effect: decline; RR=2.3; CI: 95% CI: 1.5, 3.6

Survivors of extranodal non-Hodgkin lymphoma had higher risks of SGA infants and low birth weight in their first live singleton birth conceived after diagnosis.

Effect: decline; RR=2.3; CI: 95% CI: 1.5, 3.6

Survivors of extranodal non-Hodgkin lymphoma had higher risks of SGA infants and low birth weight in their first live singleton birth conceived after diagnosis.

Effect: decline; RR=2.3; CI: 95% CI: 1.5, 3.6

Survivors of extranodal non-Hodgkin lymphoma had higher risks of SGA infants and low birth weight in their first live singleton birth conceived after diagnosis.

Effect: decline; RR=2.3; CI: 95% CI: 1.5, 3.6

Survivors of extranodal non-Hodgkin lymphoma had higher risks of SGA infants and low birth weight in their first live singleton birth conceived after diagnosis.

Effect: decline; RR=2.3; CI: 95% CI: 1.5, 3.6

Survivors of extranodal non-Hodgkin lymphoma had higher risks of SGA infants and low birth weight in their first live singleton birth conceived after diagnosis.

Effect: decline; RR=2.3; CI: 95% CI: 1.5, 3.6

Survivors of extranodal non-Hodgkin lymphoma had higher risks of SGA infants and low birth weight in their first live singleton birth conceived after diagnosis.

Effect: decline; RR=2.3; CI: 95% CI: 1.5, 3.6

Survivors of extranodal non-Hodgkin lymphoma had higher risks of SGA infants and low birth weight in their first live singleton birth conceived after diagnosis.

Effect: decline; RR=2.3; CI: 95% CI: 1.5, 3.6

Survivors of extranodal non-Hodgkin lymphoma had higher risks of SGA infants and low birth weight in their first live singleton birth conceived after diagnosis.

Effect: decline; RR=2.3; CI: 95% CI: 1.5, 3.6

Brain cancer survivors had a higher risk of small for gestational age infants, with 15% (16/104) born SGA, though only 1 of 16 SGA infants was small enough to be classified low birth weight at term.

Effect: decline; RR=1.7; CI: 95% CI: 1.1, 2.8

Brain cancer survivors had a higher risk of small for gestational age infants, with 15% (16/104) born SGA, though only 1 of 16 SGA infants was small enough to be classified low birth weight at term.

Effect: decline; RR=1.7; CI: 95% CI: 1.1, 2.8

Brain cancer survivors had a higher risk of small for gestational age infants, with 15% (16/104) born SGA, though only 1 of 16 SGA infants was small enough to be classified low birth weight at term.

Effect: decline; RR=1.7; CI: 95% CI: 1.1, 2.8

Brain cancer survivors had a higher risk of small for gestational age infants, with 15% (16/104) born SGA, though only 1 of 16 SGA infants was small enough to be classified low birth weight at term.

Effect: decline; RR=1.7; CI: 95% CI: 1.1, 2.8

Brain cancer survivors had a higher risk of small for gestational age infants, with 15% (16/104) born SGA, though only 1 of 16 SGA infants was small enough to be classified low birth weight at term.

Effect: decline; RR=1.7; CI: 95% CI: 1.1, 2.8

Brain cancer survivors had a higher risk of small for gestational age infants, with 15% (16/104) born SGA, though only 1 of 16 SGA infants was small enough to be classified low birth weight at term.

Effect: decline; RR=1.7; CI: 95% CI: 1.1, 2.8

Brain cancer survivors had a higher risk of small for gestational age infants, with 15% (16/104) born SGA, though only 1 of 16 SGA infants was small enough to be classified low birth weight at term.

Effect: decline; RR=1.7; CI: 95% CI: 1.1, 2.8

Brain cancer survivors had a higher risk of small for gestational age infants, with 15% (16/104) born SGA, though only 1 of 16 SGA infants was small enough to be classified low birth weight at term.

Effect: decline; RR=1.7; CI: 95% CI: 1.1, 2.8

Brain cancer survivors had a higher risk of small for gestational age infants, with 15% (16/104) born SGA, though only 1 of 16 SGA infants was small enough to be classified low birth weight at term.

Effect: decline; RR=1.7; CI: 95% CI: 1.1, 2.8

Brain cancer survivors had a higher risk of small for gestational age infants, with 15% (16/104) born SGA, though only 1 of 16 SGA infants was small enough to be classified low birth weight at term.

Effect: decline; RR=1.7; CI: 95% CI: 1.1, 2.8

Brain cancer survivors had a higher risk of small for gestational age infants, with 15% (16/104) born SGA, though only 1 of 16 SGA infants was small enough to be classified low birth weight at term.

Effect: decline; RR=1.7; CI: 95% CI: 1.1, 2.8

Brain cancer survivors had a higher risk of small for gestational age infants, with 15% (16/104) born SGA, though only 1 of 16 SGA infants was small enough to be classified low birth weight at term.

Effect: decline; RR=1.7; CI: 95% CI: 1.1, 2.8

Brain cancer survivors had a higher risk of small for gestational age infants, with 15% (16/104) born SGA, though only 1 of 16 SGA infants was small enough to be classified low birth weight at term.

Effect: decline; RR=1.7; CI: 95% CI: 1.1, 2.8

Brain cancer survivors had a higher risk of small for gestational age infants, with 15% (16/104) born SGA, though only 1 of 16 SGA infants was small enough to be classified low birth weight at term.

Effect: decline; RR=1.7; CI: 95% CI: 1.1, 2.8

Brain cancer survivors had a higher risk of small for gestational age infants, with 15% (16/104) born SGA, though only 1 of 16 SGA infants was small enough to be classified low birth weight at term.

Effect: decline; RR=1.7; CI: 95% CI: 1.1, 2.8

Brain cancer survivors had a higher risk of small for gestational age infants, with 15% (16/104) born SGA, though only 1 of 16 SGA infants was small enough to be classified low birth weight at term.

Effect: decline; RR=1.7; CI: 95% CI: 1.1, 2.8

Brain cancer survivors had a higher risk of small for gestational age infants, with 15% (16/104) born SGA, though only 1 of 16 SGA infants was small enough to be classified low birth weight at term.

Effect: decline; RR=1.7; CI: 95% CI: 1.1, 2.8

Brain cancer survivors had a higher risk of small for gestational age infants, with 15% (16/104) born SGA, though only 1 of 16 SGA infants was small enough to be classified low birth weight at term.

Effect: decline; RR=1.7; CI: 95% CI: 1.1, 2.8

Brain cancer survivors had a higher risk of small for gestational age infants, with 15% (16/104) born SGA, though only 1 of 16 SGA infants was small enough to be classified low birth weight at term.

Effect: decline; RR=1.7; CI: 95% CI: 1.1, 2.8

Brain cancer survivors had a higher risk of small for gestational age infants, with 15% (16/104) born SGA, though only 1 of 16 SGA infants was small enough to be classified low birth weight at term.

Effect: decline; RR=1.7; CI: 95% CI: 1.1, 2.8

Brain cancer survivors had a higher risk of small for gestational age infants, with 15% (16/104) born SGA, though only 1 of 16 SGA infants was small enough to be classified low birth weight at term.

Effect: decline; RR=1.7; CI: 95% CI: 1.1, 2.8

Brain cancer survivors had a higher risk of small for gestational age infants, with 15% (16/104) born SGA, though only 1 of 16 SGA infants was small enough to be classified low birth weight at term.

Effect: decline; RR=1.7; CI: 95% CI: 1.1, 2.8

Brain cancer survivors had a higher risk of small for gestational age infants, with 15% (16/104) born SGA, though only 1 of 16 SGA infants was small enough to be classified low birth weight at term.

Effect: decline; RR=1.7; CI: 95% CI: 1.1, 2.8